tbuckley/cabot-search huggingface dataset:
Collaborative Intelligence to catalyze the digital transformation of healthcare
Authors: Ami B. Bhatt, Jennifer Bae
Journal: npj Digital Medicine (2023)

Abstract Collaborative intelligence reflects the promise and limits of leveraging artificial intelligence (AI) technologies in clinical care. It involves the use of advanced analytics and computing power with an understanding that humans bear responsibility for the accuracy, completeness and any inherent bias found in the training data. Clinicians benefit from using this technology to address increased complexity and information overload, support continuous care and optimized resource allocation, and to enact efforts to eradicate disparities in health care access and quality. This requires active clinician engagement with the technology, a general understanding of how the machine produced its insight, the limitations of the algorithms, and the need to screen datasets for bias. Importantly, by interacting, the clinician and the analytics will create trust based on the clinician’s critical thinking skills leveraged to discern value of machine outputs within clinical context. Utilization of collaborative intelligence should be staged with the level of understanding and evidence. It is particularly well suited to low-complexity non-urgent care and to identifying individuals at rising risk within a population. Clinician involvement in algorithm development and the amassing of evidence to support safety and efficacy will propel adoption. Utilization of collaborative intelligence represents the natural progression of health care innovation, and if thoughtfully constructed and equitably deployed, holds the promise to decrease clinician burden and improve access to care.
Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells
Authors: Jagannath Padmanabhan, Kellen Chen, Dharshan Sivaraj, Dominic Henn, Britta A. Kuehlmann, Hudson C. Kussie, Eric T. Zhao, Anum Kahn, Clark A. Bonham, Teruyuki Dohi, Thomas C. Beck, Artem A. Trotsyuk, Zachary A. Stern-Buchbinder, Peter A. Than, Hadi S. Hosseini, Janos A. Barrera, Noah J. Magbual, Melissa C. Leeolou, Katharina S. Fischer, Seth S. Tigchelaar, John Q. Lin, David P. Perrault, Mimi R. Borrelli, Sun Hyung Kwon, Zeshaan N. Maan, James C. Y. Dunn, Rahim Nazerali, Michael Januszyk, Lukas Prantl, Geoffrey C. Gurtner
Journal: Nature Biomedical Engineering (2023)

Abstract Small animals do not replicate the severity of the human foreign-body response (FBR) to implants. Here we show that the FBR can be driven by forces generated at the implant surface that, owing to allometric scaling, increase exponentially with body size. We found that the human FBR is mediated by immune-cell-specific RAC2 mechanotransduction signalling, independently of the chemistry and mechanical properties of the implant, and that a pathological FBR that is human-like at the molecular, cellular and tissue levels can be induced in mice via the application of human-tissue-scale forces through a vibrating silicone implant. FBRs to such elevated extrinsic forces in the mice were also mediated by the activation of Rac2 signalling in a subpopulation of mechanoresponsive myeloid cells, which could be substantially reduced via the pharmacological or genetic inhibition of Rac2 . Our findings provide an explanation for the stark differences in FBRs observed in small animals and humans, and have implications for the design and safety of implantable devices.
IL-12 sensing in neurons induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice
Authors: Myrto Andreadou, Florian Ingelfinger, Donatella De Feo, Teresa L M Cramer, Selma Tuzlak, Ekaterina Friebel, Bettina Schreiner, Pascale Eede, Shirin Schneeberger, Maria Geesdorf, Frederike Ridder, Christina A Welsh, Laura Power, Daniel Kirschenbaum, Shiva K Tyagarajan, Melanie Greter, Frank L Heppner, Sarah Mundt, Burkhard Becher
Journal: Nature Neuroscience (2023)

Abstract Interleukin-12 (IL-12) is a potent driver of type 1 immunity. Paradoxically, in autoimmune conditions, including of the CNS, IL-12 reduces inflammation. The underlying mechanism behind these opposing properties and the involved cellular players remain elusive. Here we map IL-12 receptor (IL-12R) expression to NK and T cells as well as neurons and oligodendrocytes. Conditionally ablating the IL-12R across these cell types in adult mice and assessing their susceptibility to experimental autoimmune encephalomyelitis revealed that the neuroprotective role of IL-12 is mediated by neuroectoderm-derived cells, specifically neurons, and not immune cells. In human brain tissue from donors with multiple sclerosis, we observe an IL-12R distribution comparable to mice, suggesting similar mechanisms in mice and humans. Combining flow cytometry, bulk and single-nucleus RNA sequencing, we reveal an IL-12-induced neuroprotective tissue adaption preventing early neurodegeneration and sustaining trophic factor release during neuroinflammation, thereby maintaining CNS integrity in mice.
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
Authors: Sneha Vishwanath, George William Carnell, Matteo Ferrari, Benedikt Asbach, Martina Billmeier, Charlotte George, Maria Suau Sans, Angalee Nadesalingam, Chloe Qingzhou Huang, Minna Paloniemi, Hazel Stewart, Andrew Chan, David Arthur Wells, Patrick Neckermann, David Peterhoff, Sebastian Einhauser, Diego Cantoni, Martin Mayora Neto, Ingo Jordan, Volker Sandig, Paul Tonks, Nigel Temperton, Simon Frost, Katharina Sohr, Maria Teresa Lluesma Ballesteros, Farzad Arbabi, Johannes Geiger, Christian Dohmen, Christian Plank, Rebecca Kinsley, Ralf Wagner, Jonathan Luke Heeney
Journal: Nature Biomedical Engineering (2023)

The threat of spillovers of coronaviruses associated with the severe acute respiratory syndrome (SARS) from animals to humans necessitates vaccines that offer broader protection from sarbecoviruses. By leveraging a viral-genome-informed computational method for selecting immune-optimized and structurally engineered antigens, here we show that a single antigen based on the receptor binding domain of the spike protein of sarbecoviruses elicits broad humoral responses against SARS-CoV-1, SARS-CoV-2, WIV16 and RaTG13 in mice, rabbits and guinea pigs. When administered as a DNA immunogen or by a vector based on a modified vaccinia virus Ankara, the optimized antigen induced vaccine protection from the Delta variant of SARS-CoV-2 in mice genetically engineered to express angiotensin-converting enzyme 2 and primed by a viral-vector vaccine (AZD1222) against SARS-CoV-2. A vaccine formulation incorporating mRNA coding for the optimized antigen further validated its broad immunogenicity. Vaccines that elicit broad immune responses across subgroups of coronaviruses may counteract the threat of zoonotic spillovers of betacoronaviruses.
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Authors: Alessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, Serena Pelusi, Eniada Rrapaj, Elia Casirati, Giulia Passignani, Marjan Norouziesfahani, Elena Sinopoli, Guido Baselli, Clara Meda, Paola Dongiovanni, Daniele Dondossola, Neil Youngson, Aikaterini Tourna, Shilpa Chokshi, Elisabetta Bugianesi, Luisa Ronzoni, Cristiana Bianco, Laura Cerami, Veronica Torcianti, Giulia Periti, Sara Margarita, Rossana Carpani, Francesco Malvestiti, Ilaria Marini, Melissa Tomasi, Angela Lombardi, Jessica Rondena, Marco Maggioni, Roberta D’Ambrosio, Valentina Vaira, Anna Ludovica Fracanzani, Chiara Rosso, Grazia Pennisi, Salvatore Petta, Antonio Liguori, Luca Miele, Federica Tavaglione, Umberto Vespasiani-Gentilucci, Marcello Dallio, Alessandro Federico, Giorgio Soardo, Jussi Pihlajamäki, Ville Männistö, Sara Della Torre, Daniele Prati, Stefano Romeo, Luca Valenti
Journal: Nature Medicine (2023)

Abstract Fatty liver disease (FLD) caused by metabolic dysfunction is the leading cause of liver disease and the prevalence is rising, especially in women. Although during reproductive age women are protected against FLD, for still unknown and understudied reasons some develop rapidly progressive disease at the menopause. The patatin-like phospholipase domain-containing 3 ( PNPLA3 ) p.I148M variant accounts for the largest fraction of inherited FLD variability. In the present study, we show that there is a specific multiplicative interaction between female sex and PNPLA3 p.I148M in determining FLD in at-risk individuals (steatosis and fibrosis, P &lt; 10 −10 ; advanced fibrosis/hepatocellular carcinoma, P = 0.034) and in the general population ( P &lt; 10 −7 for alanine transaminase levels). In individuals with obesity, hepatic PNPLA3 expression was higher in women than in men ( P = 0.007) and in mice correlated with estrogen levels. In human hepatocytes and liver organoids, PNPLA3 was induced by estrogen receptor-α (ER-α) agonists. By chromatin immunoprecipitation and luciferase assays, we identified and characterized an ER-α-binding site within a PNPLA3 enhancer and demonstrated via CRISPR–Cas9 genome editing that this sequence drives PNPLA3 p.I148M upregulation, leading to lipid droplet accumulation and fibrogenesis in three-dimensional multilineage spheroids with stellate cells. These data suggest that a functional interaction between ER-α and PNPLA3 p.I148M variant contributes to FLD in women.
Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor–Positive Primary Human Breast Tumors
Authors: Hyunsoo Kim, Austin A. Whitman, Kamila Wisniewska, Rasha T. Kakati, Susana Garcia-Recio, Benjamin C. Calhoun, Hector L. Franco, Charles M. Perou, Philip M. Spanheimer
Journal: Clinical Cancer Research (2023)

Abstract Purpose: In estrogen receptor–positive (ER+)/HER2− breast cancer, multiple measures of intratumor heterogeneity are associated with a worse response to endocrine therapy. We sought to develop a novel experimental model to measure heterogeneity in response to tamoxifen treatment in primary breast tumors. Experimental Design: To investigate heterogeneity in response to treatment, we developed an operating room-to-laboratory pipeline for the collection of live normal breast specimens and human tumors immediately after surgical resection for processing into single-cell workflows for experimentation and genomic analyses. Live primary cell suspensions were treated ex vivo with tamoxifen (10 μmol/L) or control media for 12 hours, and single-cell RNA libraries were generated using the 10X Genomics droplet-based kit. Results: In total, we obtained and processed normal breast tissue from two women undergoing reduction mammoplasty and tumor tissue from 10 women with ER+/HER2− invasive breast carcinoma. We demonstrate differences in tamoxifen response by cell type and identify distinctly responsive and resistant subpopulations within the malignant cell compartment of human tumors. Tamoxifen resistance signatures from resistant subpopulations predict poor outcomes in two large cohorts of ER+ breast cancer patients and are enriched in endocrine therapy–resistant tumors. Conclusions: This novel ex vivo model system now provides the foundation to define responsive and resistant subpopulations within heterogeneous human tumors, which can be used to develop precise single cell–based predictors of response to therapy and to identify genes and pathways driving therapeutic resistance.
Nanoassembly of doxorubicin-conjugated polyphosphoester and siRNA simultaneously elicited macrophage- and T cell- mediated anticancer immune response for cancer therapy
Authors: Dongdong Li, Ziyang Cao, Chaoran Chen, Hengyi Li, Shan He, Xurui Hou, Ming Liang, Xianzhu Yang, Jun Wang
Journal: Biomaterials (2023)
42708 Prediction of Breslow thickness of melanoma using a Deep Learning Algorithm
Authors: Juan-Carlos Hernández-Rodríguez, Juan Ortiz-Álvarez, Rosa Corbi-Llopis, Mercedes Morillo-Andújar, Julián Conejo-Mir, José-Juan Pereyra-Rodríguez
Journal: Journal of the American Academy of Dermatology (2023)
43312 Long term psoriasis control with guselkumab versus secukinumab and ixekizumab among bio- experienced patients: analysis of drug persistence in large claims database
Authors: Maryia Zhdanava, Timothy Fitzgerald, Dominic Pilon, Rachel Teneralli, Aditi Shah, Christopher Holiday, Patrick Lefebvre, Steven Feldman
Journal: Journal of the American Academy of Dermatology (2023)
42805 Effects of Moisturizers on Skin Barrier Function in Patients with Chronic Kidney Disease on Hemodialysis
Authors: Yeon Joo Jung, Heeyeon Kim, Jai Hee Bae, Donghwi Jang, Joon Ho Shim, Se Jin Oh, Jong Hee Lee, Ji-Hye Park
Journal: Journal of the American Academy of Dermatology (2023)
43372 Efficacy and Tolerability of Stabilized Topical Retinol for Signs of Skin Aging: An Integrated Analysis of 6 Placebo-Controlled Studies
Authors: Patricia Farris, Diane Berson, Neal Bhatia, David Goldberg, Edward Lain, Kavita Mariwalla, Joshua Zeichner, Lamar Blackwell, Dara Miller, James McGuire, Menas Kizoulis
Journal: Journal of the American Academy of Dermatology (2023)
43038 Long term psoriasis control with guselkumab versus secukinumab and ixekizumab among bio- naïve patients: analysis of drug persistence in large claims database
Authors: Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Rachel Teneralli, Aditi Shah, Christopher Holiday, Patrick Lefebvre, Steven Feldman
Journal: Journal of the American Academy of Dermatology (2023)
43614 Nonthermal Atmospheric Plasma for the Treatment of Molluscum Contagiosum and Verruca Vulgaris in Pediatric Patients
Authors: Chelsea Shope, Laura Andrews, Kelly Atherton, Courtney Linkous, Tyler Beck, Gabriella Santa Lucia, Peter Friedman, Colleen Cotton, Lara Wine Lee
Journal: Journal of the American Academy of Dermatology (2023)
43018 Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata From 2 Randomized Clinical Trials over a Median of 1.6 years and up to 3.6 Years of Exposure
Authors: Brett King, Justin Ko, Bianca Maria Piraccini, Yutaka Shimomura, Yves Dutron, Wen-Shuo Wu, Fan Emily Yang, Katrin Holzwarth, Chiara Chiasserini, Rodney Sinclair
Journal: Journal of the American Academy of Dermatology (2023)
44095 Response to Abrocitinib up to Week 96 According to Short-Term Response: A Post Hoc Analysis of the JADE-EXTEND Phase 3 Trial
Authors: Jonathan I. Silverberg, Kristian Reich, Marjolein de Bruin-Weller, Mette Deleuran, Lisa A. Beck, Kim Papp, Saleem A. Farooqui, Fan Zhang, Claire Feeney, Melissa Watkins
Journal: Journal of the American Academy of Dermatology (2023)
42317 Dupilumab Normalizes Epidermal Hyperplasia Protein Expression and Improves Clinical Outcome in Patients with Moderate-to-Severe Atopic Dermatitis
Authors: Elena Goleva, Evgeny Berdyshev, Simion Kreimer, Taras Lyubchenko, Shantanu Bafna, Inoncent Agueusop, Robert Bissonnette, Noah Levit, Annie Zhang, Donald Leung
Journal: Journal of the American Academy of Dermatology (2023)
43140 Impact of Sarecycline on Quality of Life in Skin of Color Patients with Acne Vulgaris: Post Hoc Analysis of Phase 3 Trials
Authors: Andrew Alexis, Hilary Baldwin, Jonette Keri, Emmy Graber, Francisco Hernandez, Raidah Salem, Paul Tomondy, Julie Harper
Journal: Journal of the American Academy of Dermatology (2023)
42136 Lebrikizumab improvement in itch reduction at 52 weeks in patients with moderate-to-severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials
Authors: Gil Yosipovitch, Peter Lio, David Rosmarin, Franz Legat, Jose Manuel Carrascosa, Eric Meskimen, Marta Casillas, Evangeline Pierce, Zhuqing Liu, Jinglin Zhong, Sonja Ständer
Journal: Journal of the American Academy of Dermatology (2023)
42002 Clinical efficacy and safety of Dupilumab for the treatment of moderate to severe atopic dermatitis in Korea
Authors: Jongwook Kim, Yeona Kim, Sang-Hyeon Won, Kyung-Nam Bae, Jungsoo Lee, Kihyuk Shin, Hoonsoo Kim, Hyunchang Ko, Moon-Bum Kim, Byungsoo Kim
Journal: Journal of the American Academy of Dermatology (2023)
42247 Tailored dermocosmetic regimens for perimenopausal and menopausal women improved self- esteem and quality of life
Authors: Stephanie LECLERC. MERCIER, Delphine KEROB, Marita KOSMADAKI, Elia ROÓ, Thierry HAAG, Christos ZOUBOULIS
Journal: Journal of the American Academy of Dermatology (2023)
42037 Phase 2a Study of Efficacy and Safety of Crisaborole in Patients with Stasis Dermatitis Using a Decentralized Evaluation Method
Authors: Jonathan I. Silverberg, Robert S. Kirsner, David Margolis, Michael Tharp, Daniela E. Myers, Karen Annis, Daniela Graham, Chuanbo Zang, Bonnie L. Vlahos, Paul Sanders
Journal: Journal of the American Academy of Dermatology (2023)
43781 Evaluation of the miR-326 miRNA level in RDEB associated fibrosis
Authors: Anoop Kumar, Rahul Mahajan, Dipankar De, Vinod Kumar, Sanjeev Handa, Reena Das, Biman Saikia, Devajyoti Chatterjee, Uma Nahar
Journal: Journal of the American Academy of Dermatology (2023)
43978 Treatment-Emergent Adverse Events of Interest for Janus Kinase Inhibitors: Pooled Analysis of the 52-Week TRuE-V Phase 3 Studies of Ruxolitinib Cream Treatment for Vitiligo
Authors: Amit G. Pandya, Khaled Ezzedine, David Rosmarin, Thierry Passeron, Seemal R. Desai, Mark Lebwohl, Deanna Kornacki, Kang Sun, Kathleen Butler, Albert Wolkerstorfer
Journal: Journal of the American Academy of Dermatology (2023)
43001 Phase 1 study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis
Authors: Omid Hamid, Amy Weise, Karl D. Lewis, Tae Min Kim, Meredith McKean, Nehal J. Lakhani, John Kaczmar, Kyriakos P. Papadopoulos, Shuquan Chen, Jayakumar Mani, Giuseppe Gullo
Journal: Journal of the American Academy of Dermatology (2023)
43986 Effectiveness in real world practice after fifty-two weeks of Risankizumab treatment for patients with moderate-to-severe psoriasis: thirty-one patient cohort
Authors: Maria Dolores Benedicto-Maldonado, Pedro Jose Navarro Guillamon, Sara Merino Molina, Jorge Alonso Suarez Perez, Enrique Herrera Acosta
Journal: Journal of the American Academy of Dermatology (2023)
<i>N</i>‐Acetylcysteine‐Derived Carbon Dots for Free Radical Scavenging in Intervertebral Disc Degeneration (Adv. Healthcare Mater. 24/2023)
Authors: Shang Wu, Yu Shi, Letao Jiang, Wenzhen Bu, Kai Zhang, Wenzheng Lin, Chun Pan, Zhuobin Xu, Jianwei Du, Hao Chen, Huihui Wang
Journal: Advanced Healthcare Materials (2023)
42898 Efficacy and tolerance of a keratolytic and hydrating shampoo in subjects with mild to moderate psoriasis: results from a double-blind, randomized, vehicle-controlled study conducted under real-life conditions
Authors: Delphine Kerob, Philippe Massiot, Pedreo Contreiras Pinto, Bianca Maria Piraccini, Lidia Rudnicka, Daniel Fernandes Melo, Sergio Vano, Wen-Yu Wu, Stephanie Leclerc-Mercier
Journal: Journal of the American Academy of Dermatology (2023)
43857 A novel pre-clinical trial platform for evaluating candidate hypo- or hyperpigmentation- inducing agents identifies menthol as a UV-free tanning agent ex vivo
Authors: Max van Lessen, Andrei Mardaryev, Jeremy Chéret, Marta Bertolini, Janin Edelkamp, Maximilian Kückelhaus, Wolfgang Funk, Desmond Tobin, Tamas Bíró, Ralf Paus
Journal: Journal of the American Academy of Dermatology (2023)
41808 Effectiveness, safety and survival of guselkumab in patients with moderate-to-severe psoriasis after 156 weeks, in real clinical practice
Authors: Lourdes Rodriguez Fernandez-Freire, Ricardo Ruiz Villaverde, Jose Carlos Armario Hita, Amalia Perez Gil, Fiorella Vasquez Chinchay, Fatima Moreno Suarez, Leandro Martinez Pilar, Manuel Galan Gutierrez
Journal: Journal of the American Academy of Dermatology (2023)
Entangling of Peptide Nanofibers Reduces the Invasiveness of SARS‐CoV‐2 (Adv. Healthcare Mater. 24/2023)
Authors: Pei‐Pei Yang, Xin‐Wei Ye, Mei‐Qin Liu, Jin‐Xuan Yang, Xiao‐Li Feng, Yi‐Jing Li, Kuo Zhang, Hong‐Wen Liang, Yu Yi, Lei Wang, Yi‐Xuan Liu, Xing‐Lou Yang, Zheng‐Li Shi, Li‐Qiang Feng, Ling Chen, Yintong Xue, Qiang Pan‐Hammarström, Hao Wang, Yuliang Zhao
Journal: Advanced Healthcare Materials (2023)
42628 Laterality of Biophysical Parameters of the Skin in a Normal Population
Authors: Heeyeon Kim, Yeon Joo Jung, Jai Hee Bae, Donghwi Jang, Joon Ho Shim, Se Jin Oh, Jong Hee Lee, Dong-Youn Lee, Ji Hye Park
Journal: Journal of the American Academy of Dermatology (2023)
41958 Efficacy and safety of topical agents for moderate-to-severe papulopustular rosacea: a systematic review and network meta-analysis
Authors: Esraa Shaheen, Yara Aljefri, Abeer Alhindi, Abdullah Ghaddaf, Khalid Alshareef, Anwar Alrashidi, Narin Alanazi, Abdulhadi Jfri
Journal: Journal of the American Academy of Dermatology (2023)
40116 Evaluating the impact of the exposome on skin aging in 11 locations in Argentina by questionnaire and artificial intelligence diagnostic
Authors: Giselle Claros, Mariana Lequio, Santiago Cheli, Agustin Bollea Garlatti, Noelia Cecilia, Lucrecia Juarez, Mario Bittar, María José Leiva, Maria Laura Hernandez, Juan Manuel Marquez, Guillermo Badaracco
Journal: Journal of the American Academy of Dermatology (2023)
43073 Pharmacokinetics, Safety and Pharmacodynamics of VTX2735, A Potent and Selective NLRP3 Inhibitor, In Healthy Adult Volunteers
Authors: William Sandborn, Richard Gregg, Kathleen Ogilvie, Fei Liu, Snehal Naik, Beatriz Lindstrom, Shendong Yuan, John Nuss
Journal: Journal of the American Academy of Dermatology (2023)
43697 A survey study to understand inter-rater diﬀerences in lesions counts for hidradenitis suppurativa clinical trials
Authors: Lindsey Greenlund, Claire Herzog, Zachary Wendland, Bisma Khalid, Joslyn Kirby, Afsaneh Alavi, Michelle Lowes, Angelo Marzano, Noah Goldfarb
Journal: Journal of the American Academy of Dermatology (2023)
42299 Long-term safety and efficacy of 1% clascoterone cream in patients &lt;12 years old with acne vulgaris
Authors: Lawrence F. Eichenfield, Adelaide A. Hebert, Linda Stein Gold, Martina Cartwright, Luigi Moro, Jenny Han, Nicholas Squittieri, Alessandro Mazzetti
Journal: Journal of the American Academy of Dermatology (2023)
42618 Associations Between Psoriasis and Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms: A Systematic Review and Meta-Analysis
Authors: Katrina Haught, Rika Matsuo, William Guo, Sean Na, Kimberly Lu, Tara Kaufmann, Katherine Siamas
Journal: Journal of the American Academy of Dermatology (2023)
44217 Itch and Sleep Improvements in a Pooled Analysis of Neurokinin-1 Receptor Antagonist Tradipitant in Atopic Dermatitis
Authors: Jesse Carlin, Jennifer Brzezynski, Alyssa Kaden, Changfu Xiao, Christos Polymeropoulos, Gunther Birznieks, Mihael Polymeropoulos
Journal: Journal of the American Academy of Dermatology (2023)